Errata (DOI:10.1016/S1474-4422(08)70090-5);Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

The Lancet Neurology

Volumn 7, Issue 6, 2008, Pages 483-493

  Wilcock, Gordon K ^a   Black, Sandra E ^b   Hendrix, Suzanne B ^c   Zavitz, Kenton H ^c   Swabb, Edward A ^c   Laughlin, Mark A ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

^c Myriad Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; GALANTAMINE; GLUCOSE; PLACEBO; RIVASTIGMINE; TARENFLURBIL;

ADULT; AGED; AGITATION; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CAUSE OF DEATH; CLINICAL TRIAL; COGNITION; CONFIDENCE INTERVAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DEPRESSION; DIARRHEA; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; EFFECT SIZE; EOSINOPHILIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NAUSEA; PARALLEL DESIGN; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINOPHARYNGITIS; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; URINE INCONTINENCE; VOMITING;

EID: 43249122280     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(08)70128-5     Document Type: Erratum

References (26)